Hyderabad: Biological E. Limited (BE) today received Emergency Use Authorisation (EUA) from the Drugs Controller General of India (DCGI) for the administration of its Corbevax vaccine in children aged 12…
The “nocebo effect” accounted for more than two-thirds of the common side effects people experience after a Covid-19 vaccination rather than the vaccine itself, according to a new study. The…
New Delhi: Following the results obtained from clinical trials, ChemRar Group announced that the Russian version of globally recognised drug Favipiravir, Avifavir, is highly effective against various variants of COVID…
Bengaluru : US-based Equillium Inc., Biocon’s partner, has expanded its EQUALISE study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Itolizumab (ALZUMAb-L) to clinical centers in India. EQUALISE is…
Gennova Biopharmaceuticals, subsidiary of Pune-based drugmaker Emcure which is developing mRNA Covid vaccine said it plans to finish the Phase 2/3 trials by January end next year and will seek…
Bharat Biotech’s Covaxin received nod from Subject Expert Committee (SEC) on Tuesday who further proffered positive recommendation to DCGI for the use of Covaxin in 2-18 years age group. Bharat…
By Gaurav GuptaThe Pharmaceutical industry has been a relatively slow respondent to the adoption of new technologies. However, the COVID-19 pandemic acted as a catalyst to this long-brewing revolutionary change…
LUCKNOW: The Central Drug Research Institute (CDRI) on Tuesday claimed that the clinical trials of antiviral drug, Umifenovir, in treatment of Covid-19 have been successful. The trial of Umifenovir on…
